BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $546,850 | +32.2% | 3,753 | +7.6% | 0.02% | +60.0% |
| Q1 2022 | $413,691 | -78.8% | 3,489 | -75.4% | 0.02% | -44.4% |
| Q4 2021 | $1,951,114 | -3.4% | 14,158 | -2.6% | 0.03% | -6.9% |
| Q3 2021 | $2,019,335 | +126.3% | 14,537 | +11.4% | 0.03% | +123.1% |
| Q1 2021 | $892,309 | -22.9% | 13,055 | -3.3% | 0.01% | -23.5% |
| Q4 2020 | $1,157,514 | +10.1% | 13,505 | -6.0% | 0.02% | -10.5% |
| Q2 2020 | $1,050,883 | +100.0% | 14,374 | +14.1% | 0.02% | +111.1% |
| Q3 2019 | $525,505 | +15.2% | 12,596 | +21.0% | 0.01% | +12.5% |
| Q2 2019 | $455,985 | -14.9% | 10,413 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $535,957 | +39.2% | 10,413 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $385,073 | – | 10,413 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |